307 related articles for article (PubMed ID: 24533058)
21. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
22. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
23. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
24. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
25. Pricing and availability of some essential child specific medicines in Odisha.
Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
[TBL] [Abstract][Full Text] [Related]
26. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
27. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
28. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines.
Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060
[TBL] [Abstract][Full Text] [Related]
29. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China.
Xi X; Li W; Li J; Zhu X; Fu C; Wei X; Chu S
BMC Health Serv Res; 2015 Aug; 15():345. PubMed ID: 26310243
[TBL] [Abstract][Full Text] [Related]
30. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
31. Availability of Essential Medicines in a Country in Conflict: A Quantitative Insight from Yemen.
Mohamed Ibrahim MI; Alshakka M; Al-Abd N; Bahattab A; Badulla W
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33383771
[TBL] [Abstract][Full Text] [Related]
32. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
33. Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.
Wang H; Sun Q; Vitry A; Nguyen TA
Asia Pac J Public Health; 2017 May; 29(4):268-277. PubMed ID: 28397532
[TBL] [Abstract][Full Text] [Related]
34. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala.
Anson A; Ramay B; de Esparza AR; Bero L
Global Health; 2012 Jul; 8():22. PubMed ID: 22747646
[TBL] [Abstract][Full Text] [Related]
35. Availability, affordability and costs of pediatric medicines in Mongolia.
Dorj G; Sunderland B; Sanjjav T; Dorj G; Gendenragchaa B
BMC Pediatr; 2018 May; 18(1):149. PubMed ID: 29720129
[TBL] [Abstract][Full Text] [Related]
36. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
[TBL] [Abstract][Full Text] [Related]
37. Availability of medicines in public sector health facilities of two North Indian States.
Prinja S; Bahuguna P; Tripathy JP; Kumar R
BMC Pharmacol Toxicol; 2015 Dec; 16():43. PubMed ID: 26699711
[TBL] [Abstract][Full Text] [Related]
38. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
39. Price, availability and affordability of medicines.
Mhlanga BS; Suleman F
Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
[TBL] [Abstract][Full Text] [Related]
40. Accessibility of Medicines for Children: A Systematic Review.
Chen Z; Li S; Zeng L; Liu Y; Zhang M; Choonara I; Zhang L
Front Pharmacol; 2021; 12():691606. PubMed ID: 34421594
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]